Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors

Breast Cancer Research and Treatment

Volumn 40, Issue 2, 1996, Pages 187-196

  Olsson, H ^a   Jernstrom H ^a   Alm, P ^a   Kreipe, H ^b   Ingvar, C ^a   Jonsson P E ^c   Ryden S ^d  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF KIEL   (Germany)

^c HELSINGBORG HOSPITAL   (Sweden)

^d Angelholm Hospital   (Sweden)

Author keywords

Benign breast; Family history; Ki S5; Menstrual cycle phase; Proliferation

Indexed keywords

HORMONE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; BREAST REDUCTION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN TISSUE; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTIVARIATE ANALYSIS; NULLIPARA; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION;

EID: 0029836095     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806214     Document Type: Article

References (16)

1. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE: Increased cell division as a cause of human cancer. Cancer Research 50: 7415-7421, 1990
2. Christov K, Chew KL, Ljung BM, Waldman FM, Duarte L, Goodson WH III, Smith HS, Mayall BH: Proliferation of normal breast epithelial cells as shown by in vivo labeling with bromodeoxyuridine. Am J Pathol 138: 1371-1377, 1991
3. Meyer JS, McDivitt RW, Stone KR, Prey MU: Practical breast carcinoma cell kinetics: review and update. Breast Cancer Research and Treatment 4: 79-88, 1984
4. Going JJ, Anderson TJ, Battersby S, MacIntyre CCA: Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 130: 193-204, 1988
5. Ferguson DJP, Anderson TJ: Morphological evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breast. Br J Cancer 44: 177-181, 1981
6. Longman SM, Buehring GC: Oral contraceptives and breast cancer. In vitro effect of steroids on human mammary cell growth. Cancer 59: 281-287, 1987
7. Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M, Howell A: The effect of age and the menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58: 163-170, 1988
8. Anderson T, Battersby S, King R, McPherson K, Going JJ: Oral contraceptive use influences resting breast proliferation. Hum Pathol 20: 1139-1144, 1989
9. Kreipe H, Wacker HH, Heidebrecht HJ, Haas K, Hauberg M, Tiemann M, Parwaresch R: Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Am J Pathol 142: 1689-1694, 1993
10. Williams G, Anderson E, Howell A, Watson R, Coyne J, Roberts SA, Potten CS: Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer 48: 206-210, 1991
11. Longacre TA, Bartow SA: A correlative morphological study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10: 382-393, 1986
12. Olsson H, Möller TR, Ranstam J: Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden. J Natl Cancer Inst 81: 1000-1004, 1989
13. Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative disease. N Engl J Med 312: 146-151, 1985
14. Murray PP, Stadel BV, Schesselman JJ: Oral contraceptive use in women with a family history of breast cancer. Obstet Gynecol 73: 977-983, 1989
15. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Morris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: Isolation of BRCA 1, the 17q-linked breast and ovarian cancer susceptibility gene. Science 266: 66-71, 1994
16. Futreal P, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Söderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R: BRCA 1 mutations in primary breast and ovarian carcinomas. Science 266: 120-121, 1994